Zarate-Garza, Pablo Patricio MD; Biggs, Bridget K. PhD; Croarkin, Paul DO; Morath, Brooke BSc; Leffler, Jarrod PhD; Cuellar-Barboza, Alfredo MD; Tye, Susannah J. PhD
From the Department of Psychiatry, Autonomous University of Nuevo Leon (Mexico) (Drs. Zarate-Garza and Cuellar-Barboza); Departments of Psychiatry and Psychology (Drs. Zarate-Garza, Biggs, Croarkin, Leffler, and Tye, and Ms. Morath), and of Molecular Pharmacology and Experimental Therapeutics (Dr. Tye), Mayo Clinic, Rochester, MN; Department of Psychiatry, University of Minnesota (Dr. Tye).
Supported by National Institute of Mental Health K23 grant no. MH100266 (Dr. Croarkin) and State of Minnesota Mayo-Minnesota Partnership Award (Dr. Tye).
Correspondence: Susannah J. Tye, Department of Psychiatry & Psychology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905. Email: [email protected]